Intravenous administration of lisinopril
Pro Research Analysisby 
Searched over 200M research papers
Intravenous Lisinopril: Pharmacokinetics and Bioavailability
Intravenous (IV) administration of lisinopril results in much higher bioavailability compared to oral dosing. In patients with chronic heart failure, urinary recovery of lisinopril after IV administration is about 88%, while it is only 15% after oral dosing, indicating that absorption from the gut is limited in these patients. The reduced oral absorption is likely due to the disease state and possibly age, but IV administration bypasses these limitations and leads to higher serum concentrations than those seen in healthy individuals after oral dosing 24. In healthy volunteers, IV administration also shows predictable pharmacokinetics, with a two-compartment model best describing the drug’s distribution and elimination 37.
Hemodynamic Effects of Intravenous Lisinopril
IV lisinopril produces a significant and rapid reduction in mean arterial pressure (MAP) in patients with chronic heart failure. The maximal hypotensive effect after IV lisinopril is similar to that of oral lisinopril, but the onset is faster and the peak effect occurs earlier (e.g., -25 mm Hg at 105 minutes for IV vs. -19 mm Hg at 210 minutes for oral). This rapid onset can be beneficial in acute settings where quick blood pressure control is needed 14. The hemodynamic benefits include reductions in mean arterial pressure, pulmonary capillary wedge pressure, and systemic vascular resistance, with no significant changes in heart rate or cardiac index .
Duration of Action and ACE Inhibition
Both oral and IV lisinopril provide potent inhibition of the renin-angiotensin-aldosterone system, with effects lasting over 24 hours. However, the time course of the blood pressure-lowering effect differs, with IV administration leading to a more immediate response . The terminal elimination phase of lisinopril after IV dosing is prolonged, likely due to binding to angiotensin-converting enzyme (ACE), but the effective half-life for accumulation is shorter, supporting once-daily dosing .
Comparative Efficacy and Safety
When compared to other ACE inhibitors like enalapril and enalaprilat, IV lisinopril’s hypotensive effect is similar in magnitude and time course to IV enalaprilat, but more pronounced and rapid than IV enalapril. All treatments are generally well tolerated, though there is a risk of symptomatic hypotension, especially with more potent or rapid-acting agents .
Special Considerations: Central and Systemic Effects
IV lisinopril, like other ACE inhibitors, can cross the blood-brain barrier and may have central effects, such as upregulating the cough reflex through accumulation of bradykinin and substance P in the central nervous system . This is a consideration for side effect profiles, especially in sensitive individuals.
Conclusion
Intravenous administration of lisinopril offers rapid, predictable, and potent blood pressure reduction, with high bioavailability and strong inhibition of the renin-angiotensin-aldosterone system. It is particularly useful in acute care settings or in patients with impaired oral absorption. However, clinicians should monitor for hypotension and be aware of potential central side effects such as cough. Overall, IV lisinopril is an effective option for managing blood pressure and heart failure when oral administration is not feasible or effective 1234+2 MORE.
Sources and full results
Most relevant research papers on this topic